← Open Payments lookup

GLENN SCHWARCZ: Open Payments

NPI 1952481996 · MONSEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 31 payments from 11 companies in 2025. Trend: 2023 $827 · 2024 $240 · 2025 $784

Food & beverage: $784
CompanyPaymentsAmount
ABBVIE INC.8$249
Alkermes, Inc.4$102
Otsuka America Pharmaceutical, Inc.5$94
E.R. Squibb & Sons, L.L.C.3$63
Teva Pharmaceuticals USA, Inc.2$58
Lundbeck LLC2$54
Biogen, Inc.2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Neurocrine BioSciences, Inc.1$26
Janssen Pharmaceuticals, Inc1$25

Products named: VRAYLAR, ARISTADA, ABILIFY MAINTENA, REXULTI, COBENFY, AUSTEDO XR, ZURZUVAE, CAPLYTA.

Industry payments across NY — which companies pay providers there.